How has ImmunityBio, Inc.'s gains (losses) - FVO: changes in fair value changed year-over-year?

ImmunityBio, Inc.'s gains (losses) - FVO: changes in fair value decreased by 455.7% year-over-year, from -$42.58M to -$236.63M.

What does gains (losses) - FVO: changes in fair value mean?

This metric reflects the non-cash gains or losses resulting from the company's election to measure certain financial instruments at fair value. It captures the impact of market price changes on these specific assets or liabilities on the income statement.

ImmunityBio, Inc. IBRX Gains (losses) - FVO: changes in fair value

Gains (losses) - FVO: changes in fair value at other companies

Columbia Banking SystemsCOLB

-$2M-129%

MIT

TPG Mortgage Investment Trust MITT

-$16.46M-2,152%

MIT

TPG Mortgage Investment Trust MITT

-$16.46M-2,152%

MIT

TPG Mortgage Investment Trust MITT

-$118K-1,280%

ImmunityBio, Inc.IBRX

-$236.63M-456%

Intercontinental ExchangeICE

$0—

Segments

By segment

See full

Reportable Segment-$236.63M-456%

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FairValueOptionChangesInFairValueGainLoss1.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s gains (losses) - fvo: changes in fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s gains (losses) - FVO: changes in fair value?: ImmunityBio, Inc. (IBRX) reported gains (losses) - FVO: changes in fair value of -$236.63M in Q1 2026.
How has ImmunityBio, Inc.'s gains (losses) - FVO: changes in fair value changed year-over-year?: ImmunityBio, Inc.'s gains (losses) - FVO: changes in fair value decreased by 455.7% year-over-year, from -$42.58M to -$236.63M.
What does gains (losses) - FVO: changes in fair value mean?: This metric reflects the non-cash gains or losses resulting from the company's election to measure certain financial instruments at fair value. It captures the impact of market price changes on these specific assets or liabilities on the income statement.